iSpecimen Will Serve as a Preferred Provider of Cancer Biospecimens

Stock Information for iSpecimen Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About iSpecimen Inc.

iSpecimen Approached by Crypto Currency Companies for $200 Million Treasury Discussions
iSpecimen Announces Completion of Milestone 1 in Digital Transformation Journey with Salestack Platform
iSpecimen to Establish $200M Corporate Treasury Built Around Solana Cryptocurrency with BlockArrow
iSpecimen Inc. Announces Closing of Approximately $1.75 Million Private Placement Priced At-the-Market
iSpecimen Inc. Announces Pricing of Approximately $1.75 Million Private Placement Priced At-the-Market
Correction: iSpecimen Inc. Announces Closing of $4 Million Underwritten Offering
Correction: iSpecimen Inc. Announces Pricing of $4 Million Underwritten Offering
iSpecimen Inc. Announces Closing of $4 Million Underwritten Offering

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.